Mural Oncology
MURA
MURA was delisted on the 4th of December, 2025.
76 hedge funds and large institutions have $29.8M invested in Mural Oncology in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 28 reducing their positions, and 20 closing their positions.
8.53% less ownership
Funds ownership: 64.41% → 55.88% (-8.5%)
12% less funds holding
Funds holding: 86 → 76 (-10)
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
50% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 28
77% less capital inflows, than outflows
Capital inflows: $1.34M | Capital outflows: $5.71M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$354K |
| 2 |
Prosight Management
Dallas,
Texas
|
+$310K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$205K |
| 4 |
Two Sigma Investments
New York
|
+$130K |
| 5 |
Millennium Management
New York
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$2.33M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$556K |
| 3 |
Goldman Sachs
New York
|
-$421K |
| 4 |
Primecap Management
Pasadena,
California
|
-$311K |
| 5 |
AGM
Alpine Global Management
New York
|
-$294K |
MURA Hedge Fund Activity: Q3 2024 in Review
76 of the 6,989 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q3 2024, worth a combined $29.8M — down 13% from $34.2M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of MURA and 10 opened new positions — a net loss of 10 holders — while 28 trimmed existing stakes and 14 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $354K. The largest seller was Westfield Capital Management, exiting entirely with an estimated $2.33M sold.
- 76 institutional investors held Mural Oncology (MURA) as of Q3 2024, down from 86 in Q2 2024.
- Funds reported $29.8M of Mural Oncology stock for Q3 2024, down 13% quarter-over-quarter.
- 10 funds opened new Mural Oncology positions in Q3 2024 and 20 closed out, a net change of -10 holders.
- The largest Mural Oncology buyer in Q3 2024 was Point72 Asset Management, an estimated $354K added.
- The largest Mural Oncology seller in Q3 2024 was Westfield Capital Management, an estimated $2.33M sold.
Based on aggregated 13F filings for Q3 2024.